Cargando…
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
Today there is plausible evidence both on experimental and epidemiological basis, that hyperuricemia represents a risk factor for the development and progression of chronic kidney disease (CKD). Nevertheless, the role of serum uric acid lowering treatment in CKD is still a matter of serious controve...
Autores principales: | Eleftheriadis, Theodoros, Golphinopoulos, Spyridon, Pissas, Georgios, Stefanidis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512148/ https://www.ncbi.nlm.nih.gov/pubmed/28748122 http://dx.doi.org/10.1016/j.jare.2017.05.001 |
Ejemplares similares
-
A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease
por: Tziastoudi, Maria, et al.
Publicado: (2021) -
Role of indoleamine 2,3-dioxygenase in ischemia-reperfusion injury of renal tubular epithelial cells
por: Eleftheriadis, Theodoros, et al.
Publicado: (2021) -
Inhibition of Malate Dehydrogenase-2 Protects Renal Tubular Epithelial Cells from Anoxia-Reoxygenation-Induced Death or Senescence
por: Eleftheriadis, Theodoros, et al.
Publicado: (2022) -
Cytochrome c as a Potentially Clinical Useful Marker of Mitochondrial and Cellular Damage
por: Eleftheriadis, Theodoros, et al.
Publicado: (2016) -
Factors that May Protect the Native Hibernator Syrian Hamster Renal Tubular Epithelial Cells from Ferroptosis Due to Warm Anoxia-Reoxygenation
por: Eleftheriadis, Theodoros, et al.
Publicado: (2019)